as of Oct 26
A
GrowthAGILENT TECHNOLOGIES INC.
Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems.
Close · 3M
+32.53%
Held by 1 AI ETF
Signal performance
Each tracked ETF's moves on this stock, grouped by fund. Returns are measured from the signal date to the latest close — hypothetical, no commissions or slippage.
AIEQ · Weight increase · 2d
weight 0.760% → 0.790% (+0.030 pp)·stock up 5.2% in the 30 days before
Oct 22·entry $173.89·now $173.07Fresh
AIEQ · Weight increase · 2d
weight 0.550% → 0.780% (+0.230 pp)·stock up 11.2% in the 30 days before
Oct 1·entry $166.68·now $173.07Drifting
AIEQ · Accumulation · 5d
weight 0.470% → 0.530% (+0.060 pp)·stock up 7.7% in the 30 days before
Sep 23·entry $165.32·now $173.07Drifting
AIEQ · Accumulation · 5d
weight 0.460% → 0.510% (+0.050 pp)·stock up 5.2% in the 30 days before
Sep 22·entry $167.26·now $173.07Drifting
AIEQ · Weight increase · 4d
weight 0.460% → 0.500% (+0.040 pp)·stock up 0.7% in the 30 days before
Sep 18·entry $156.47·now $173.07Chased
AIEQ · Weight increase · 3d
weight 0.460% → 0.490% (+0.030 pp)·stock up 5.3% in the 30 days before
Sep 17·entry $156.34·now $173.07Chased
AIEQ · Weight increase · 2d
weight 0.460% → 0.480% (+0.020 pp)·stock up 3.5% in the 30 days before
Sep 16·entry $153.69·now $173.07Chased
AIEQ · Weight decrease · 2d
weight 0.480% → 0.460% (-0.020 pp)·stock up 6.7% in the 30 days before
Sep 4·entry $150.86·now $173.07
AIVL · Exit · 1d
weight 0.824% → 0 (exited)·stock up 8.8% in the 30 days before
Sep 2·entry $151.39·now $173.07
AIVL · Accumulation · 5d
weight 0.789% → 0.840% (+0.051 pp)·stock up 12.4% in the 30 days before
Aug 27·entry $157.69·now $173.07Drifting
AIVL · Accumulation · 5d
weight 0.787% → 0.822% (+0.035 pp)·stock up 10.3% in the 30 days before
Aug 26·entry $155.08·now $173.07Chased
AIVL · Accumulation · 6d
weight 0.780% → 0.826% (+0.045 pp)·stock up 12.2% in the 30 days before
Aug 25·entry $154.77·now $173.07Chased
AIVL · Accumulation · 5d
weight 0.787% → 0.818% (+0.032 pp)·stock up 10.7% in the 30 days before
Aug 24·entry $153.43·now $173.07Chased
AIVL · Accumulation · 5d
weight 0.787% → 0.849% (+0.062 pp)·stock up 13.8% in the 30 days before
Aug 21·entry $159.00·now $173.07Drifting
AIVL · Weight increase · 4d
weight 0.780% → 0.835% (+0.055 pp)·stock up 17.1% in the 30 days before
Aug 20·entry $156.30·now $173.07Chased
AIVL · Weight increase · 3d
weight 0.780% → 0.825% (+0.045 pp)·stock up 17.0% in the 30 days before
Aug 19·entry $155.41·now $173.07Chased
AIVL · Weight increase · 2d
weight 0.780% → 0.789% (+0.009 pp)·stock up 14.0% in the 30 days before
Aug 18·entry $148.44·now $173.07Chased
AIVL · Accumulation · 5d
weight 0.751% → 0.796% (+0.045 pp)·stock up 11.5% in the 30 days before
Aug 11·entry $149.49·now $173.07Chased
AIVL · Weight increase · 3d
weight 0.749% → 0.790% (+0.041 pp)·stock up 10.7% in the 30 days before
Aug 10·entry $148.72·now $173.07Chased
AIVL · Weight increase · 2d
weight 0.749% → 0.774% (+0.025 pp)·stock up 9.3% in the 30 days before
Aug 7·entry $145.97·now $173.07Chased
AIVL · Weight increase · 3d
stock up 10.3% in the 30 days before
Jul 23·entry $139.74·now $173.07Chased
AIVL · Weight increase · 2d
stock up 5.5% in the 30 days before
Jul 22·entry $133.46·now $173.07Chased
AIVL · Weight increase · 2d
stock down 0.9% in the 30 days before
Jul 10·entry $134.29·now $173.07Chased
Sell signals show what the stock did after the AI exited. A negative number means the AI's exit was well-timed.
Buffett-style framework
AI ETF AIVL had recently accumulated shares but subsequently executed a full exit, while AIEQ also shows a trend of decreasing its weight in Agilent. This aligns with the framework's 'Fail' verdict, which primarily stems from the lack of a sufficient margin of safety at current prices.
- Circle of CompetenceThe business of providing life science tools and services, including recurring consumables and maintenance, exhibits sufficiently stable unit economics to reasonably project cash flows over a decade.
- Economic MoatAgilent benefits from significant customer switching costs due to integrated instrument platforms and specialized consumables, alongside a strong brand reputation for accuracy and reliability in scientific markets.
- ManagementThe provided financial data does not offer sufficient information to assess management's candor, capital allocation discipline, or alignment of interests.
- Financial HealthKey metrics like 10-year average ROE, operating margins, debt levels, and owner earnings are not provided, preventing a comprehensive assessment of financial health.
- Margin of SafetyThe current valuation multiples, including a PER of 29.54 and EV/EBITDA of 35.3, suggest the market is pricing in significant future growth, leaving little to no margin of safety based on conservative intrinsic value estimates.
Agilent Technologies operates within a predictable circle of competence, underpinned by a durable economic moat from high switching costs and brand reputation. However, a comprehensive assessment of management and financial health is incomplete due to data limitations. Critically, the current market price does not offer a margin of safety, making it unattractive from a value-investing perspective, despite the underlying business quality.
Educational interpretation generated by AI applying frameworks Warren Buffett documented in his shareholder letters and other public writings. Not a statement by Mr. Buffett or Berkshire Hathaway, and not investment advice.